Neuropace, Inc. - Common Stock (NPCE)
9.3200
+0.1900 (2.08%)
NASDAQ · Last Trade: Aug 13th, 5:13 PM EDT

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Via Benzinga · May 31, 2025

Via Benzinga · May 28, 2025
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via Chartmill · May 27, 2025
NeuroPace's RNS System trial showed a strong safety profile and subgroup efficacy in drug-resistant epilepsy, prompting FDA pathway discussions.
Via Benzinga · May 27, 2025
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · May 27, 2025
Via Benzinga · May 27, 2025
In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · May 27, 2025
Via Benzinga · May 27, 2025
Via Benzinga · May 14, 2025
Via Benzinga · April 9, 2025

Via Benzinga · January 7, 2025

Via Benzinga · December 26, 2024

U.S. stock futures were lower this morning, with the Dow futures falling over 100 points on Thursday.
Via Benzinga · December 26, 2024